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NORTH AMERICA
Manuel Cerdas Calderon
Manuel Cerdas Calderon is the Professor of Medicine, University of Medical Sci-
ences, San Jose, Costa Rica. In addition, he serves as the Nephrology Fellowship Train-
ing Program Director, Costa Rican University; and Clinical Chief of the Nephrology
Service, Mexico Hospital, San Jose, Costa Rica. He received his medical degree from
the University of Costa Rica, his Internal Medicine Residency at the Mexico Hospi-
tal, San Jose, Costa Rica, and completed his Nephrology Fellowship at the Universi-
dad Autonoma de Mexico, at Instituto Nacional de Cardiologı´a Ignacio Chaves. Dr.
Calderon belongs to the Latin American Society of Nephrology and Hypertension, the
ASN, the National Kidney Foundation, and the ISN. He was the President of Costa Ri-
can Nephrology Society and Vice-President Latin American Society of Nephrology. He
has been a member of the ISN COMGAN Subcomission for Latin America. His re-
search interests include dialysis, kidney transplant, and chronic renal failure. He states
that his vision and plans for the ISN would be to work to facilitate the tools of the
ISN to promote international collaboration, educational programs, and clinical research
projects in the low-income countries. In addition, he would work to emphasize the
social responsibility of the pharmaceutical and dialysis industry to the needs of the
underdeveloped countries. He also calls for the creation of programs in the field of
prevention of the progression of the renal disease unique to the idiosyncrasy of each
country.
Steven Hebert
Steven Hebert received his undergraduate degree from Florida State University and
his medical degree from the University of Florida. He was an Assistant Professor at the
University of Alabama and the University of Texas prior to his appointment as Assis-
tant Professor and then Professor at Harvard Medical School. He then became the Ann
and Roscoe R. Robinson Professor and Chief of the Division of Nephrology and Hy-
pertension at Vanderbilt University. He currently is CNH Long Professor and Chair of
the Department of Cell and Molecular Physiology/Professor of Medicine at Yale Uni-
versity School of Medicine. Dr. Hebert was the Chair of the ASN Program Committee
and Co-Chair of the Basic Science Committee. In addition, he served the ISN as Vice-
Chair of the Program Committee and a member of the Program Committee. He has
served on the councils of the APS, EI AHA, ASCI, AAP, and AAAS. He has been the
recipient of the Gottschalk Award (APS), Homer Smith Award (ASN), and the A.N.
Richards Award (ISN). He has served on the Editorial Boards of Kidney Blood Pres-
sure Research, Journal of Membrane Biology, Journal of Clinical Investigation, American
Journal of Physiology: Renal, American Journal of Physiology: Cell. He was the section
editor of Current Opinions in Nephrology and Hypertension and editor of American
Journal of Physiology Renal and Annals of Reviews of Physiology-Renal. Finally, he
was editor of the fourth edition of The Kidney, Physiology and Pathophysiology (2004).
Dr. Hebert is the founder and on the board of Marical, Inc. He holds a patent on a
calcium-sensing receptor. His research includes molecular physiology/pathophysiology
of salt transport by kidney, cloned Na/K/Cl and Na/Cl cotransporters, renal K channel,
ROMK, and the calcium-sensing receptor, which is the target for calcimimetic/calcilytic
drugs. His stated goals for the ISN are to expand/stimulate international coopera-
tive science and the translation of basic science to new diagnostic and therapeutic
advances.
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Richard J. Johnson
Richard J. Johnson is the J. Robert Cade Professor and Chief of Nephrology, Hyper-
tension and Transplantation at the University of Florida. Dr. Johnson has lectured in 25
countries and has been on the Editorial Board of Kidney International, Journal of the
American Society of Nephrology, American Journal of Kidney Disease, American Journal
of Physiology, and American Journal of Nephrology. He has had NIH funding since 1986
and has published over 300 articles, and is recognized by the ISI Web of Science as one
of the 250 most cited scientists in “Clinical Medicine” between 1982 and 2002 (with more
than 11,000 citations). He is Co-Editor with Dr. John Feehally of the highly regarded
textbook, Comprehensive Clinical Nephrology. He was an organizer for the ISN meeting
in Madrid and will do the same in Sydney. He is currently an ISN councilor filling in
for the vacancy of Dr. Tom Coffman. His major scientific contributions have focused on
the role of glomerular and tubulointerstitial cells in renal progression, the role of subtle
renal injury in the development of salt-sensitive hypertension, and the role of uric acid
in hypertension and renal disease. He also has performed clinical studies on hepatitis C
virus-induced glomerulonephritis and studies on the epidemiology and etiology of renal
diseases in Peru.
Adeera Levin
Adeera Levin was born in Australia but now lives in Canada. Currently, she is a Pro-
fessor of Medicine at University of British Columbia, Co-Director of the Clinical In-
vestigator Program, and was Program Director for Nephrology. Her diverse educational
background includes an undergraduate degree from the University of Toronto, in the
classics, a medical degree and internal medicine training at McMaster University, and
nephrology, clinical, and research training at the University of Toronto. Currently, she is
the Chair of the Kidney Foundation (Canada) Biomedical Fellowship and Scholarship
Committee. In addition, she serves as Chair of the Curriculum Committee for a new
innovative clinical scientist-training program. She is the Chair of the National Kidney
Foundation K/DOQI guideline process and member of KDIGO. Finally, she is the Exec-
utive Director of the British Columbia Provincial Renal Agency. Her research and clinical
activities focus on chronic kidney disease and its comorbidities, mechanisms of disease,
and health outcomes. She mentors young investigators in kidney-related research. She
cites that her current interests, international activities, research interests, mentoring, and
leadership roles, are in agreement with those of the ISN, which could help to improve the
care of kidney patients worldwide. The NA role would permit dissemination of key goals
of the ISN and identify key partnership opportunities.
Nathan Levin
Nathan Levin’s interests in the practice and research in kidney disease and dialysis
patients extend over several decades. At different levels of organization he has partici-
pated in many “kidney-related” societies and associations. In recent years, he has been
a member of the initial USRDS and an active investigator in the major NIH dialysis
clinical trials (NCDS, HEMO, CHOICE, and now DAILY DIALYSIS) and has been in-
tellectually rewarded. Being Co-Chair of DOQI and K/DOQI, and now part of KDIGO,
have been great opportunities to influence medical quality. Service in the Association
for the Advancement of Medical Instrumentation for 20 years has permitted an effect
on technology development. His close relationship with the ISN includes Chair of the
Hemodialysis Advisory Committee, Chair of the hemodialysis theme for the WCN in
2005 in Singapore, initially introducing K/DOQI into COMGAN, and helping to estab-
lish the Kaplan Prize in polycystic kidney disease. A major challenge he sees for the ISN
is improvement of care and outcomes in areas where facilities and training are deficient.
To accomplish this goal requires a broad international view and narrow specificity in
facilities. Some tools include technical training, education in management, improvement
of communication skills, and application of appropriate economic principles. Continuing
respect for, and recognition of, progress is essential.
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David Warnock
David Warnock serves as the Director of the Division of Nephrology at the Uni-
versity of Alabama at Birmingham. His research interests involve hypertension and
basic physiologic mechanisms of salt and electrolyte transport. He is the Associate
Editor of the Journal of the American Society of Nephrology Renal Transport and
Cell Physiology. He serves as the principal investigator for Renal REGARDS, which
is addressing the associations between stroke, heart disease, and chronic kidney dis-
ease in a cohort of 30,000 subjects in the United States. The scope of their activities
(more than 600 dialysis patients, more than 300 kidney transplants/year, and exten-
sive chronic renal replacement therapy) also supports very active clinical services in
which he is fully involved. He is currently the President of the National Kidney Foun-
dation in the United States, with its programs addressing chronic kidney disease, the
K/DOQI, and the Kidney Early Evaluation Program. A global approach to the defi-
nition and optimal treatment of kidney diseases is critically important and represents
an important opportunity for the ISN and other affiliated organizations to impact on




Hirokazu Imai has been a most prolific investigator. He has introduced ddY mice
as a spontaneous model of IgA nephropathy and proposed that human membranous
nephropathy is IgG4 deposition disease. He has analyzed peritoneal function on continu-
ous ambulatory peritoneal dialysis patients and reviewed Japanese cases with hematopoi-
etic stem cell transplantation-related nephropathy. He still works in both experimental
and clinical areas. He has contributed as a member of Committee Secretaries of the
Japanese Society of Nephrology to release information to the fellows of the Japanese
Society of Nephrology (JSN) by e-mail and to receive constructive comments from JSN
members. He is also a director of the under- and postgraduate education committee con-
sisting of almost 50 active members, working on self-assessment programs and seminar
for students and residents. His ISN goals include the building of a new network and to
make a new educational system under the concept of the global advancement of nephrol-
ogy. He believes that the globalization in nephrology does not mean the enforcement of
global standards, but the coordination between global standards and local decisions.
Philip Kam-Tao Li
Philip Kam-Tao Li is Chief of Nephrology, Prince of Wales Hospital, Chinese University
of Hong Kong, Hong Kong. His current positions in the international nephrology commu-
nity include Chairman of the Hong Kong Society of Nephrology, Council Member of the
Asian Pacific Society of Nephrology, Founding Editor-in-Chief of the Hong Kong Journal
of Nephrology, Associate Editor of the American Journal of Kidney Disease, and Deputy
Editor of Nephrology. He is also on the Editorial Board of Peritoneal Dialysis Interna-
tional. Dr. Li is a member of the ISN COMGAN Committee for East Asia, the ISN Mem-
bership & Marketing Committee, the Scientific Vice President of the ISPD, the President
of the Organizing Committee, ISN 2004 Conference of Prevention of Progression of Renal
Disease, and the President of the Organizing Committee, 11th Congress of ISPD in 2006. It
is among his objectives to advance academic nephrology in the Asian Pacific region and to
promote patient rehabilitation. He would continue to capitalize on his excellent relation-
ship with various nephrology societies worldwide and his strong academic background of
over 220 international publications to promote nephrology training and research, preven-
tion of kidney diseases, and wider application of peritoneal dialysis in the Asian Pacific
region.
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ASIA SOUTH
Georgi Abraham
Georgi Abraham is a Professor at Sri Ramachandra University Hospital, Chennai,
India. His research includes cardiovascular and bone disease, adequacy of dialysis, nu-
trition, anemia, and care of live donors. He has published 90 papers and authored five
textbook chapters. He initiated continuous ambulatory peritoneal disease in India after
his training in Toronto, Canada, and established the Peritoneal Dialysis Society of India,
which facilitated the expansion of the procedure. He is the Editor of Indian Journal of
Peritoneal Dialysis, council member for ISPD, and international adviser for Royal College
of Physicians of London. TANKER, a trust he founded, provides subsidized and free dial-
ysis for the poor, financial support for renal transplantation, and supports research. The
ISN runs a model sister center program between his unit and the Toronto Hospital. He
received the international distinguished medal in Nephrology 2003 by National Kidney
Foundation America. His goals for the ISN, if he were to be elected as a council member,
would be to engage with his colleagues in the ISN to broadly promote educational activ-
ities for doctors and health care professionals in the prevention and early detection of
kidney diseases in South Asia and other developing countries. He has a vision to provide
low-cost dialysis therapy to many more needy patients in the community by partnership
with the ISN, industry, government, and South Asians in developed countries.
Vivekanand Jha
Vivekanand Jha is Additional Professor of Nephrology at the Postgraduate Institute of
Medical Education and Research (PGI), Chandigarh. He trained at the PGI, at BIDMC,
and at Harvard University. His research areas include acute renal failure, posttransplant
infections (tuberculosis, cytomegalovirus, BK virus), socioeconomic aspects of chronic
kidney disease care, commerce in transplantation, referral patterns, and early detection
of kidney diseases. He is the first nephrologist to establish a basic science laboratory
in India and is directing Bioinformatics development across India as Taskforce Expert.
He has published more than 100 papers and 22 textbook chapters (Oxford Textbook of
Nephrology, Oxford Textbook of Medicine, and Massry’s The Kidney) and is an Asso-
ciate Editor of the Indian Journal of Nephrology. He is a member of the Interventional
Nephrology Commission of the ISN, National Academy of Medical Sciences of India,
and former councilor of the Asian-Pacific Society of Nephrology. He is on the Board of
Directors of Kidney Disease-Improving Global Outcomes (an NKF-USA initiative). He
oversees a Web site (www.pginephro.org) with physician and patient resources for devel-
oping countries. He has been invited for lectureships and to chair scientific sessions at
several meetings, including the WCN and Transplantation. To further ISN goals, he would
take initiatives to extend kidney disease care to the community, and develop high-quality
translational research in developing countries.
MIDDLE EAST
Behrooz Broumand
Behrooz Broumand was born and educated in Iran. He received his diplomat, doctor
of medicine from Tehran Medical School and his medical degree from Tehran Univer-
sity and served for 2 years as a general practitioner in the north of Iran. He began his
residency training in Hackensack, New Jersey and then did his medical residency at the
Georgetown Medicine of DC General Hospital, followed by a fellowship in nephrology
and nephropathology at AFIP Washington DC. He is certified from the American Board
of Internal Medicine and the American Board of Nephrology. He was Assistant Professor
of Medicine at George Washington University before he returned to Iran. He is a member
of the ISN. Dr. Broumand is currently Professor of Medicine, IUMS. He was President of
the Iranian Society of Nephrology from 1976 to 1980 and again from 2000 to the present
time. He served on the Editorial Board of Nephron and Archives of Iranian Medicine.
He is a Fellow of the ACP and was recertified by the American Board of Nephrology
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and Medicine. His goals for the ISN include an attempt, with the guidance of ISN, to
encourage Middle Eastern countries to participate in cooperative studies, both nationally
and regionally, to prevent ESRD and in the basic sciences. He also would like to reorganize
ISN meetings in the region.
Riyad Said
Riyad Said was born in Palestine, graduated from Cairo University Medical School,
and trained in both Internal Medicine and Nephrology at Northwestern University in
the United States. He is a member of the American Board of Internal Medicine and
American Board of Nephrology. He is the current President of the Jordan Society of
Nephrology, past President of the Arab Society of Nephrology and Renal Transplanta-
tion, founding member of the ASNRT Cairo, Executive Board Member of the ASNRT,
Treasurer of the ASNRT, Secretary General of the ASNRT, and finally, the President of
the ASNRT. He is a member of the ISN and COMGAN representative for the Middle
East Region for the last 3 years. Dr. Said is currently Professor of Medicine and Nephrol-
ogy, Jordan University–Medical School. In addition, he is Director of Medical Education
and Training at Jordan Hospital, Amman. He has authored more than 50 publications
in the field of nephrology in both local, regional, and international journals. He will be
the President of the forthcoming 9th Congress of the Arab Society of Nephrology and
Renal Transplantation in Amman, Jordan. His goals for the ISN include working with
other council members to help in improving and strengthening the relation between the
ISN and regional societies, especially in the emerging world through the different exist-
ing programs, COMGAN, ISN’s Renal Sister Center program, and fellowship programs
hoping to achieve the ISN global health equity goals in renal care.
AFRICA
Adel Afifi
Adel Afifi is Professor of Internal Medicine and Nephrology, Ain Shams University,
Cairo. He is a graduate of Ain Shams University, Cairo. He was the founder and Presi-
dent of the National Kidney Foundation–Egypt, Vice President of the Egyptian Society
of Nephrology, and Co-Chairman, Education Committee, International Federation of
Kidney Foundations. Dr. Afifi is a member of the Executive Committee, International
Federation of Kidney Foundations, and founder and President of the Egyptian Renal
Data Registry. In addition, he is Vice President of the Middle East Society of Nephrol-
ogy. He has authored Understanding Kidney Diseases, 1st edition (1996) and the 2nd
edition (2003); A Manual of Nutritional Guidelines for Renal Disease Patients (1999) (in
Arabic); and The Kidney, Caring, Protecting and Curing (2003) (in Arabic). He states that
his goals for the ISN would be to form an African renal database to define the magnitude
of renal problems, form an intervention task force to manage different renal problems in
different areas according to their needs, begin training programs for nephrologists in dif-
ferent areas directed to its local renal problems, and initiate an African renal newsletter
addressing renal problems unique to Africa.
Saraladevi Naicker
Saraladevi Naicker is Professor of Renal Medicine and Head of the Division of
Nephrology at the University of the Witwatersrand, Johannesburg, South Africa. She
is Secretary of the College of Physicians of South Africa, serves on the Board of
Directors of the National Kidney Foundation (South Africa) and KDIGO and is an
Executive Committee Member of the African Association of Nephrology. She also
served on the International Posttransplant Diabetes Guidelines Committee and is a
past President of the South African Renal and Transplantation Societies. She has 95
publications and is a reviewer for the American Journal of Kidney Diseases, Biologi-
cal Chemistry, Nephrology Dialysis Transplantation, and the National Research Foun-
dation (South Africa). She serves on the Fellowships Committee of the ISN and is a
member of the following ISN COMGAN Committees: Education Advisory Committee,
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Renal Disease in Indigenous People, and Chairs the Africa Subcommittee. She has been
a member of the Nominating Committee. She has hosted ISN Fellows from Ethiopia,
Nigeria, Tanzania, and Rwanda as well as an ISPD trainee from Tanzania. She has been
nominated to receive the International Distinguished Medal of the NKF (USA) for sig-
nificant contribution to nephrology. She is committed to advancing nephrology by pro-
moting nephrology education and training, as well as establishing chronic kidney disease
prevention programs in Africa.
EUROPE
La´szlo´ Rosivall
La´szlo´ Rosivall is Head of Nephrology Research Group of Hungarian Academy of
Sciences and Semmelweis University. In addition, he has served many prestigous posi-
tions, including President of Semmelweis University, President of Worldwide Hungarian
Medical Academy, Vice-Chairman of Central and Eastern European Subcommittee of
COMGAN, Council member and Chairman of Renal Commission at International Soci-
ety for Pathophysiology, founder and President of Hungarian Kidney Foundation, Head
of the first nephrology doctorate program in Hungary, and founder of the Budapest
Nephrology Summer School. He has brought experiences from Bergen, Birmingham,
Harvard, Montpellier, Heidelberg, and Tulane universities. His interests include renal
hemodynamics, renin-angiotensin system, and fibrosis from molecules to bedside. He
serves on the Editorial Boards of several peer-reviewed journals. He has published 110 ar-
ticles, 62 chapters, and one textbook. In addition, he holds one patent. His life is dedicated
to the development of nephrology by educating a new generation of skillful nephrologists.
He believes in wider cooperation between basic and clinical sciences within the frame-
work of ISN, leading to less regional differences in education and practice. He believes
that local nephrology societies with support of the ISN should lobby for better recogni-
tion and support for prevention. He brings his idea of “Virtual ISN University for Global
Nephrology” to foster education, joint research, and patient care.
Kamil Serdengecti
Kamil Serdengecti is currently Professor at the Department of Nephrology of Istan-
bul University Cerrahpasa Faculty of Medicine (IUCFM) and President of the Turkish
Society of Nephrology (TSN). He was born in Istanbul, Turkey, and received his medical
degree from IUCFM. He specialized in internal medicine. With a British Council Schol-
arship, he worked as Research Assistant under Professor H.A. Lee at Wessex Renal Unit,
Southampton University, United Kingdom before returning to Turkey. He was appointed
Associate Professor and then Professor to the Department of Nephrology of the IUCFM.
He is Co-Founder of Turkish National Registry and is Co-Editor of its yearly booklets.
He is also President of the 42nd ERA-EDTA Congress to be held in Istanbul. He is on the
Editorial Board of Nephrology Dialysis Transplantation. He is also member of the ISN-
COMGAN Subcommission for Eastern & Central Europe. He also co-organized seven
very successful ISN-COMGAN & TSN joint meetings in Turkey. His goals for the ISN
include his commitment to pursue the ISN mission of global advancement in nephrology
further in the fields of epidemiology and prevention of renal diseases.
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MEMBERSHIP
The ISN provides an international forum for the ex-
change of knowledge, best clinical practice, and research.
Since it was founded in 1960, the Society has constantly
made major contributions to the worldwide advancement
of education, science, and patient care in nephrology.
The ISN’s more than 7000 members include re-
searchers and clinicians from over 100 countries involved
in basic, translational, and applied science. Through this
global network of professionals, the ISN is focused on
designing programs that aim to understand and diagnose
kidney disease and provide suitable treatment, either to
prevent the disease or slow its progression.
Join the ISN today and become a member of the world’s
leading network of nephrologists. Membership includes a
1-year subscription to Kidney International and a number
of other exclusive benefits.
For complete information relating to membership or
any of the ISN’s programs and activities, please visit the
Membership section of the ISN Web site at http://www.
isn-online.org or by contacting the ISN Global Headquar-
ters at Avenue de Tervueven 300, B-1150, Brussels, Bel-
gium. Telephone: +32-2-743 1546; Fax: +32-2-743 1550;
E-mail: info@isn-online.org
MEETING ANNOUNCEMENTS
The Eleventh Assisi European Meeting in Car-
dionephrology will be held in Assisi, Italy, April 7-9, 2005.
The main topics of the meeting will be epidemiologic
nephrology, infectious diseases of the cardiovascular sys-
tem in uremics, renal osteodystrophy and cardiovascu-
lar calcifications, cardiorenal anemia syndrome, emerg-
ing role of oxidative stress; endothelial dysfunction in
uremics, cardiorenal protection and dialytic membranes,
new clinical insight for aldosterone-antagonists in car-
diorenal protection, genetic modulation of hypertension,
and rare renal syndromes and cardiovascular diseases.
For further information, contact: Prof. Mario Timio, De-
partment of Nephrology, San Giovanni Battista Hospital,
06034 Foligno (Pg), Italy. Telephone: +39-0742-339762;
Fax: +39-0742-339310; E-mail: nefrofo5@asl3.umbria.it
The 2nd International Conference “New Insights II:
Progression of Chronic Kidney Disease” will be held May
8–10, 2005, in Barcelona, Spain. For further informa-
tion, contact Technical Secretariat, Sociedad Espan˜ola
de Nefrologı´a, c/Magallanes 36, 39007 Santander (Spain).
Telephone:+34 942 075 469; Fax:+34 942 231 058; E-mail:
insights@senefro.org
The European Diabetic Nephropathy Study Group
(EDNSG) will be held May 13–14, 2005, in Arnhem,
The Netherlands. For further information, contact:
Dr. Roberto Trevisan, Secretary of EDNSG, U.O. Dia-
betologia, Ospedali Riuniti di Bergamo, Largo Barozzi
l, 24128 Bergamo, Italy. Fax: +39 35 266889; E-mail: roby.
trevisan@tin.it or rtrevisan@ospediliriuniti.bergamo.it
The 14th International Vicenza Course on Hemodialy-
sis will be held May 24–27, 2005, in Vicenza, Italy. This
course on hemodialysis is held every three years in strict
collaboration with the industry of the field. A series of
lectures and pantel discussions will be held during the
days of the course. Several of the most actual and inter-
esting issues in the field of hemodialysis will be debated
and discussed by world-leading experts. For further infor-
mation, contact: Dr. Anna Saccardo, Secretariat of the
14th International Vicenza Course on Hemodialysis, Via
Bertesina, 394, 36100, Vicenza, Italy; Telephone/Fax: +39
444 993949; E-mail: info@vicenzanephrocourses.com
The Sixth International Meeting of the International
Federation of Kidney Foundations (IFKF) will be held
from May 31-June 3, 2005 in Dublin, Ireland. For further
information, contact: Mr. Mark Murphy, CEO Irish Kid-
ney Association. Fax: +353-1-837-3974; E-mail: mark-
murphy@ika.ie
The 12th International Vasculitis and ANCA Workshop
will be held June 15-18, 2005, at the German Cancer Re-
search Centre, Heidelberg, Germany. The meeting will
focus on the pathogenesis of primary, ANCA-associated
vasculitis, on novel therapeutic approaches, and on the
clinical management of critically ill patients. The regis-
tration deadline is May 1, 2005 at a reduced fee or on-
site. For further information and registration forms, see
http://www.ANCA-heidelberg.de
The 9th International Conference on Endothelins (ET-
9) will be held September 11–14, 2005, in Park City, Utah.
The conference includes talks and poster sessions ded-
icated to furthering the understanding of the biologic
and pathologic roles of endothelin. Key topics include
basic synthesis, receptors, signaling, pathways, general
and organ-specific pathogenic mechanisms, and applica-
tion of endothelin antagonists to the treatment of hu-
man disease. For further details, see http://www.int.med.
utah.edu/et9/
Visit http://www.isn-online.org/uploadedfiles/isn/e-
update/ for a complete listing of future meetings
BOOKS RECEIVED
Oxford Handbook of Dialysis: A Practical Guide to
Dialysis and How to Manage End Stage Renal Failure,
2nd edition, authored by Jeremy Levy, Julie Morgan, and
Edwina Brown. New York: Oxford University Press,
2004. ISBN 0-19-852954-6. This 903-page softbound text
is divided into 16 parts, with approximately 430 top-
ics ranging from the new patient with renal failure,
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hemodialysis, nursing a hemodialysis patient, peritoneal
dialysis, nursing issues in peritoneal dialysis, nutrition on
dialysis, special situations, complications of ESRD (ane-
mia, fluid overload, renal bone disease, cardiovascular
disease, infection, and other complications of ESRD),
death in dialysis patients, drug prescribing in patients on
dialysis, and, finally, standard documents (the UK Renal
Association, the US K/DOQI guidelines, and the Euro-
pean Best Practice guidelines). According to the Preface
to the First Edition, “Each section is subdivided so that
individual topics appear on single pages where possible,
and there is some degree of overlap between the sections
to avoid the need constantly to refer elsewhere. . .. We
have left plenty of space [each right-hand page] for the
reader to expunge our words and add their own!” In this
second edition, the authors add, “we hope the book re-
mains easy to use and read, which has always been one of
our primary aims, and that it will continue to have wide
readership, including nephrologists, renal nurses, inten-
sivists, dieticians, pharmacists, medical students, and our
own trainees and colleagues!” The text itself includes pri-
marily short paragraphs, listings, and figures. There is a
list of abbreviations at the beginning and a comprehen-
sive index at the end. The cost of this text is £24.95.
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ERRATA
PANZER U, SCHNEIDER A, STEINMETZ OM, WENZEL U, BARTH P, REINKING R, BECKER JU, HARENDZA S,
ZAHNER G, FISCHEREDER M, KRA¨MER BH, SCHLO¨NDORF D, OSTENDORF T, FLOEGE J, HELMCHEN U, and
STAHL RAK: The chemokine receptor 5 32 mutation is associated with increased renal survival in patients with
IgA nephropathy. Kidney Int 67:75–81, 2005
In the above-cited article, on page 75, Bernhard H. Kra¨mer should read Bernhard K. Kra¨mer.
The authors apologize for the error.
BIEDERMAN JI, VERA E, PANKHANIYA R, HASSET C, GIANNICO G, YEE J, and CORTES P: Effects of sulfonylureas,
a-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes. Kidney Int 67:554–565, 2005
In the above-cited article, on pages 558 and 559, Tables 1 and 2 should appear as follows:
Table 1. Characteristics of the rat experimental groups included in histologic studiesa
Diabetic
Tolazamide Tolazamide Glibenclamide GlibenclamideControl
Group treatment None None (14 mg/kg) (128 mg/kg) (0.28 mg/kg) (2.52 mg/kg)
Final number 14 57 22 21 21 24
Blood glucose 94 ± 1.3b 422 ± 9.6 416 ± 7.7 434 ± 6.7 409 ± 6.8 391 ± 7.0c
(9 months mean ± SE)
Final weight 386 ± 5.3 279 ± 5.8b 222 ± 7.0d 219 ± 4.8d 231 ± 6.4d 237 ± 4.4d
aValues are mean ± SE.
bBlood glucose concentration and body weight in all diabetic groups vs. control (P < 0.0001).
cBlood glucose concentration vs. nontreated diabetic group (P = 0.013).
dBody weight vs. nontreated diabetic group (P < 0.001).
Table 2. Characteristics of the rat experimental groups included in renal function studiesa
Diabetic
Control
Group Glibenclamide Glibenclamide (0.28 mg/kg)
treatment None None Insulin (0.28 mg/kg) plus insulin
Number 10 14 13 14 17
Blood glucose mg/dLb 93 ± 3.8c 463 ± 12.8 243 ± 22.3d 464 ± 7.6 316 ± 11.0d
Glycosylated hemoglobin% 5.0 ± 0.14c 14.6 ± 0.37 8.4 ± 0.61d,e 14.9 ± 0.46 9.1 ± 0.35d,e
Final weight g 313 ± 5.9c 246 ± 4.6 295 ± 6.2d,f 240 ± 5.8 289 ± 4.6d,f
aValues are mean ± SE.
bValue for each individual animal is the mean of all measurements over the 14-week period of observation.
cBlood glucose concentration, glycosylated hemoglobin and body weight in all diabetic groups vs. control (P < 0.001).
dBlood glucose concentration, glycosylated hemoglobin and body weight in all diabetic insulin-treated groups vs. noninsulin-treated (P < 0.001).
eBlood glucose concentration and glycosylated hemoglobin in all insulin-treated groups vs. control (P < 0.001).
fBody weight in all insulin-treated groups vs. control (P < 0.032).
The authors apologize for the error.
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FOR SUBMISSION OF MANUSCRIPTS
AND ANNOUNCEMENTS
Manuscripts must be submitted online to the Kidney
International Web site (http://ki.manuscriptcentral.com).
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